UNIVERSITY OF TORONTO & INCOR - CARDIOVASCULAR CONFERENCE 5-6 JULHO, 2013
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
University of Toronto & InCor
Cardiovascular Conference
5-6 Julho, 2013
Anfiteatro, Instituto do Coração
InCor-HC.FMUSP
ATTENDEES University of Toronto
Michael E. Farkouh, MD, MSc
The Director of the Heart and Stroke/ Richard Lewar Centre of Excellence in Cardiovascular Investigation and the
Peter Munk Chair in Multinational Clinical Trials at the Peter Munk Cardiac Centre, University of Toronto. He is a
graduate of the Schulich School of Medicine at Western University. Dr. Farkouh completed his internal medicine and
cardiology training at the Mayo Clinic and the Icahn School of Medicine at Mount Sinai New York and holds an MSc
in Clinical Epidemiology from McMaster University. He has published over 130 papers largely on acute coronary
syndromes and cardiovascular prevention. He has mentored many fellows and is active in teaching clinical research
methodology. Dr. Farkouh is internationally known for his work on the management of acute coronary syndromes in
the emergency room. He has a special interest and expertise in the field of cardiovascular disease in diabetic
patients. He is currently the project officer for numerous clinical trials on questions related to diabetes and heart
disease including the NIH-sponsored FREEDOM trial and coordinates clinical studies in Grenada and Colombia. Dr.
Farkouh has received the gold medal from John Paul II Hospital in Krakow and was the Teacher of the Year at the
Mayo Clinic.
Mailing address:
Area of interest: Prevention, Diabetes and Heart Disease
Primary Office
Peter Munk Cardiac Centre, University
Health Network Conference: Revascularization strategies for diabetic patients with CAD
585 University Avenue, Room 4N474
Toronto, Ontario M5G 2N2
michael.farkouh@uhn.caVlad Džavík, MD, FRCPC, FAHA
A graduate of the Faculty of Medicine at the University of Alberta, Class of 1983. After completing his Cardiology and Interventional
Cardiology training at the Ottawa Heart Institute in 1991, he joined the faculty at the University of Alberta. In 2000 he moved to
Toronto where he served as Director of the Cardiac Catheterization Laboratories and Interventional Cardiology at the Peter Munk
Cardiac Centre, University Health Network in Toronto for 11 years. Currently, he is now Deputy Head of the Division of Cardiology at
the University Health Network and Mount Sinai Hospital, and Professor of Medicine at the University of Toronto. He continues to
direct the research program in interventional cardiology. He has had an active research career, having authored or co-authored
more than 160 manuscripts in peer-reviewed journals and more than 140 abstracts in national and international scientific meetings.
His research interests range from percutaneous coronary intervention during and after acute myocardial infarction, study of optimal
therapy for cardiogenic shock, outcomes in high-risk PCI. He was the Canadian Leader and Executive Committee member of the
Occluded Artery Trial (OAT), an international collaboration studying the late open artery hypothesis, and serves as Principal
Investigator of TOSCA-2, the OAT angiographic ancillary study, having received a National Institutes of Health (US) grant to conduct
this study. He was also Principal Investigator of the international multicentre SHOCK-2 Phase 2 Trial of L-NMMA in cardiogenic
shock, and Executive Committee Member and Canadian Country Leader of TRIUMPH, the subsequent phase 3 study. He is currently
co-principal investigator of TOTAL, an international randomized trial of manual thrombectomy in patients with acute myocardial
infarction undergoing primary PCI, and study chair of EMPRES a Canadian randomized trial of exenatide to improve heart function
in also in patients undergoing primary PCI, that will begin enrolling patients shortly. Dr. Džavík is a member of the Editorial Board of
the American Heart Journal and the Canadian Cardiology Journal, and a reviewer for Circulation, Journal of the American College of
Cardiology, the American Journal of Cardiology, American Heart Journal, Critical Care Medicine and the European Heart Journal, the
Canadian Journal of Cardiology, the International Journal of Cardiology and Eurointervention, as well as the Canadian
Cardiovascular Congress, and the American College of Cardiology, American Heart Association and Transcatheter Cardiovascular
Mailing address: Therapeutics Scientific Sessions. He has also played a leadership role in the Canadian Interventional Cardiology community, having
Primary Office served as President of the Canadian Association of Interventional Cardiology between 2005 and 2007.
Toronto General Hospital
6th Floor Rm. 248
200 Elizabeth St.
Toronto, Ontario Area of interest: Interventional Cardiology and Acute Coronary Syndromes
Canada M5G 2C4
vlad.dzavi@uhn.ca
Conference: Advances in the interventional management of ACSBradley Strauss, M.D., Ph.D.
Professor
Department of Medicine, University of Toronto
Laboratory Medicine and Pathobiology, University of Toronto
Senior scientist, Molecular and cellular biology – Schulich heart research program, Sunnybrook Research Institute
Reichmann Chair, cardiovascular sciences, Sunnybrook Health Sciences Centre and University of Toronto
Director, Interventional cardiology research, Sunnybrook Health Sciences Centre
Mailing address:
Dr. Bradley Strauss has developed a novel approach to treating
patients with blocked arteries.
Primary Office
Sunnybrook Health Sciences Centre He has been experimenting with this application of collagenase
2075 Bayview Ave., Room A2 53 since the 1990s. In addition to proving the enzymes are effective
Toronto, ON
M4N 3M5 in softening plaque in coronary arteries, he has also produced a
email: bradley.strauss@sunnybrook.ca grade of collagenase safe for use in humans.
Area of interest: Translational Research and Interventional Cardiology
Conference: Pre-clinical and Clinical Research in Chronic Total OcclusionsTerrence M. Yau
B.A., M.D., C.M., M.Sc., FRCSC
Angelo and Lorenza DeGasperis Chair in Cardiovascular Surgery Research
Director, Cardiac Stem Cell Therapy Program
Director of Research, Division of Cardiovascular Surgery, Peter Munk Cardiac Centre
Professor, Department of Surgery, University of Toronto
Attending Cardiac Surgeon, Peter Munk Cardiac Centre at the University Health Network
Dr. Yau obtained his B.A. (Honors) from Johns Hopkins University in molecular biology prior to medical school
at McGill University and his surgical training at the University of Toronto. In 1998 he joined the faculty of the
Division of Cardiovascular Surgery at Toronto General Hospital. Since 1999, Dr. Yau has been the Director of
Research in the division, and is also the holder of the Angelo and Lorenza DeGasperis Chair in Cardiovascular
Surgery Research. He is a Professor in the Department of Surgery at the University of Toronto.
Dr. Yau’s clinical interests include cardiac transplantation, mechanical circulatory support, perioperative blood
conservation and cardiac intensive care. Dr. Yau conducts a number of clinical research protocols including
studies of perioperative myocardial protection, cellular transplantation for advanced heart failure, and novel
technology assessment in cardiac surgery.
In addition, Dr. Yau runs a basic science laboratory with a focus in the combination of stem cell transplantation
with gene therapy and transmyocardial revascularization, developing novel interventions for treatment of end-
Mailing address: stage heart failure. He has published extensively on a variety of clinical and basic science aspects of cardiac
Primary Office
surgery.
Toronto General Hospital
University Health Network
200 Elizabeth St. Area of interest: CT Surgery
Toronto, Ontario
Canada M5G 2C4
Conference: Stem cell therapy for myocardial repair
terry.yau@uhn.on.caHeather J Ross, MD, MHSc, FRCP(C)
Director of Cardiac Transplant
Toronto General Hospital
Heather Ross, MD, MHSc, FRCP (C), is a Professor of Medicine at the University of Toronto, and Director of the Cardiac
Transplant Program at Toronto General Hospital. She is the Ted Rogers and Family Chair in Heart Function. She is the
Head of the Ted Rogers Centre of Excellence in Heart Function and Director of Education for the University of Toronto
Transplant Institute. She received her medical degree from the University of British Columbia, Canada, her cardiology
training at Dalhousie University, and a postdoctoral fellowship in Cardiac Transplantation at Stanford University,
California. She earned her Masters Degree in Bioethics from the University of Toronto.
Dr. Ross served as the President of the Canadian Society of Transplantation in 2005, and an executive member of the
International Society for Heart & Lung Transplantation from 2002 through 2005 and Secretary Treasurer 2007-2010.
Since 2002, she has been a Supervisor for the CIHR Training Program in Regenerative Medicine, the Course Director
since 2007 and Program Advisory Committee Chair and Co-Investigator from 2008. She Chaired the ISHLT Master
Academy in Heart Failure in 2010. She was Associate Editor for the American Journal of Transplantation (2007-2010) and
is an Associate Editor for the Journal of Heart and Lung Transplantation. She served 5 years on the Canadian
Cardiovascular Society Council, 3 years on the Canadian Cardiovascular Society Executive and on the Board of the
Canadian Cardiovascular Society Academy. She was the Secretary Treasurer for the Canadian Cardiovascular Society
Academy 2010-2012. She is currently on the executive of the Heart Failure Society of America and the Vice President of
the Canadian Cardiovascular Society. She has published over 200 articles and won numerous teaching awards.
Research interests: Pharmacokinetic evaluation of immunosuppressive therapies
Heart failure and transplantation
Conference: End of Life Care in Heart FailureEric Horlick, MD CM, FRCPC, FSCAI
An interventional cardiologist at the Peter Munk Cardiac Centre and an Associate Professor of Medicine at
University of Toronto. His interests include percutaneous therapies for structural and congenital heart disease and
percutaneous valve therapy. He has delivered over 300 lectures internationally since joining the Cardiology Division
at PMCC in 2004. He has published over 70 peer reviewed papers and a number of book chapters. Dr Horlick
performed the first percutaneous pulmonary valve implant in North America with Dr Lee Benson, the first
percutaneous mitral valve repair in Canada, and the first transcatheter aortic valve in Toronto. He was intimately
involved in the development of the Sapien pulmonary valve system and educated physicians all over Europe and
the Middle East in the use of this new system. Dr Horlick has traveled extensively in North America, Europe and the
Middle East to proctor and educate physicians in structural heart disease procedures. He has served on the
program committee of several major international meetings, and is a Co-Chair of the American College of
Cardiology Structural Heart Disease Program Committee. He has been involved in developing Canadian and
International guidelines for Congenital Heart Disease and Percutaneous Valve Therapy.
Mailing address: Area of interest: Structural Heart Disease and TAVR
Eric Horlick MDCM FRCPC, Director;
Structural Heart Disease Intervention Conference: Toronto experience with TAVR: a large single centre registry
Program, Assistant Professor of Medicine,
Peter Munk Cardiac Centre, Toronto General
Hospital – University Health Network, Room
6E-249, 200 Elizabeth Street, Toronto,
Ontario, M5G 2C4.
email: eric.horlick@uhn.on.ca,kJ.E. Davies BDS, PhD, DSc, FSBE
Davies is a Full Professor at the Faculty of Dentistry, University of Toronto, and is cross-appointed
to the Institute of Biomaterials and Biomedical Engineering, and also the Faculties of both
Applied Science and Engineering, and Medicine. He is the founding President of Tissue
Regeneration Therapeutics Inc. a mesenchymal stem cell company based in Toronto. Davies
trained as an anatomist, dental surgeon and oral surgeon in the UK. His PhD, in solid-state and
surface physics, was focused on understanding electron and ion transition events in calcium
phosphates. In 1998 Davies was awarded a DSc by the University of London, England, for his
sustained contributions over 20 years to the field of Biomaterials.
Davies was recruited by the University of Toronto in 1988. He was the recipient of the
prestigious Clemson Award for Basic Research in 2000. He has edited 2 books, The Bone-
Biomaterial Interface and Bone Engineering – both of which have been heralded as key
reference works. He has also published over 200 hundred scientific papers and book chapters.
Address
He is best known internationally for his work in understanding bone healing around implanted
devices. His most recent research has focused on the harvesting, characterization, and utility of
J.E. Davies
Professor, Bone Interface Group, mesenchymal stem cells; and his discovery of the richest source of such cells in human tissue,
Faculty of Dentistry and Institute for
Biomaterials and Biomedical
from the perivascular region of the umbilical cord.
Engineering,
University of Toronto,
4 Taddle Creek Road, Toronto, Area of interest: Biomaterials and biomedical engineering
Ontario, Canada M5S 3G9.
Email: davies@ecf.utoronto.ca
Conference: IBBME at the University of Toronto and the development of MSC therapeuticsHoward Hu, M.D., M.P.H., Sc.D.
Dean & Professor, Dalla Lana School of Public Health
University of Toronto
Dr. Hu came to the University of Toronto as the Dalla Lana School of Public Health's second permanent Director and Professor in July of
2012. He is a physician-scientist, trained as an internist, occupational and environmental medicine specialist, and
epidemiologist. Previously, Dr. Hu had been Professor of Occupational and Environmental Medicine and Founding Director and PI of
the NIEHS/EPA Center for Children’s Environmental Health and Disease Research at the Harvard School of Public Health and the
Channing Laboratory of the Brigham & Women's Hospital in Boston, Massachusetts from 1988 to 2006. Most recently, Dr. Hu was the
NSF International Chair of the Department of Environmental Health Sciences, Professor of Environmental Health, Epidemiology &
Internal Medicine at the University of Michigan Schools of Public Health & Medicine from 2006 to 2012. During his tenure, the
Department recruited 14 new faculty, re-built programs, and launched several innovative initiatives in areas such as environmental
epigenetics and nutrient-toxicant interactions. Dr Hu was also the Founding Director and PI of the NIEHS P30 Core Environmental
Health Sciences Center at the University of Michigan and served as the Chair of the School-wide steering committee on global health.
Area of interest:
• Impacts of exposure to potentially toxicants that are of critical importance to public health
Mailing address:
and medicine
Primary Office
Dalla Lana School of Public • Gene-environment interactions; epigenetic dysregulation
Health
155 College Street, 6th Floor
Toronto, Ontario
Canada M5T 3M7 Conference: Air Pollution and Cardiovascular Disease: Health Impacts, Mechanisms, and
howard.hu@utoronto.ca Research OpportunitiesGreg Evans, M.A.Sc., Ph.D., P.Eng.
Director of the Southern Ontario Centre for Atmospheric Aerosol Research (SOCAAR)
University of Toronto, Faculty of Applied Science & Engineering
Dr. Evans is a Professor of Chemical Engineering and Applied Science and a former Vice-
Dean Undergraduate and Chair First Year in the Faculty of Applied Science and
Engineering at the University of Toronto. He is also the founding Director of the
greg.evans@utoronto.ca
Southern Ontario Centre for Atmospheric Aerosol Research (SOCAAR), an
interdisciplinary research centre studying the environmental and health impacts of air
pollutants. Finally, he is the Co-Leader of Engineering Leaders of Tomorrow, a leadership
development program for engineering students based in the Faculty of Applied Science
and Engineering, Leaders of Tomorrow.
Area of interest: Connections between emissions of pollutants, the quality and
composition of urban air, and the impact of aerosols on human
health and the environment.
Conference: Every breath you take: air pollution exposure and its impacts on healthPaul Dorian, MD, MSc, FRCPC
The Department Director, Division of Cardiology, University of Toronto and Staff Cardiac Electrophysiologist at St.
Michael's Hospital. He is Professor of Medicine in the Division of Cardiology and in the Division of Clinical Pharmacology at
the University of Toronto, and a Staff Scientist at the Li Ka Shing Knowledge Institute.
Dr. Dorian received his medical degree from McGill University in Montreal in 1976. He continued training in Internal
Medicine and Cardiology at the University of Toronto, and received certification by the Royal College of Physicians and
Surgeons of Canada in Internal Medicine in 1983 and certification in Cardiology in 1984. He completed training in Clinical
Pharmacology at the University of Toronto in 1982, and received an MSc in Pharmacology from the University of Toronto
in 1982. From 1983 to 1985, he completed a Fellowship in Cardiac Electrophysiology at Stanford University Medical
Centre in California.
His research interests include basic science research in advanced cardiac life support and atrial fibrillation, the clinical
pharmacology of antiarrhythmic drugs, and clinical research on implanted devices, antiarrhythmic drugs, and quality of
life in patients with arrhythmias.
He is a Co-PI on the NIH funded Resuscitation Outcomes Consortium, and serves on the steering committee of multiple
multicenter clinical trials in arrhythmia care.
He has published over 300 peer reviewed papers and is Associate Editor of the textbook Electrophysiological Disorders of
the Heart.
Mailing address:
St. Michael´s Hospital
Division of Cardiology
Rm 6-050 Queen Wing
30 Bond Street
Area of interest: Electrophysiology
Toronto, Ontario
Canada M5B 1W8 Conference: The update on atrial fibrillation: from rhythm to anticoagulation (videoconference)
dorianp@smh.toronto.on.caAdam Herman, Bio. Adam Herman, BSc, graduated from the University of British Columbia in 2010. He then worked at the BC Children’s Hospital as a Medical Laboratory Assistant for two years before moving to Toronto in the summer of 2012. Since moving to Toronto, Adam has worked as a Clinical Research Data and Regulatory Coordinator for Dr. Michael Farkouh in the division of Cardiology. Adam is enrolled in a master’s program in the fall as he continues to pursue his goal of working as a clinician/scientist.
You can also read
